- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Sodium-Glucose Transporter 2 Inhibitors
Total 16069 results
-
Scripps HealthUnknownHeart Failure, SystolicUnited States
-
National Institute of Diabetes and Digestive and...WithdrawnDiabetic Kidney Disease | Diabetes Mellitus Type 2United States
-
The University of Texas Health Science Center at...National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedInsulin Sensitivity | Multiple Mitochondrial Dysfunctions SyndromeUnited States
-
Cliniques universitaires Saint-Luc- Université...UnknownGlucose 6 Phosphatase Deficiency | Glycogen Storage Disease Type IBelgium
-
University Hospital, Basel, SwitzerlandCompleted
-
Astellas Pharma IncCompletedType 2 Diabetes MellitusJapan
-
Chinese PLA General HospitalUnknownReperfusion Injury, Myocardial
-
AstraZenecaBristol-Myers SquibbCompletedCardiovascular Disease | Type 2 Diabetes Mellitus | Inadequate Glycaemic ControlUnited States, Bulgaria, Poland, Hungary, Argentina, Australia, Austria, Canada, Germany, Chile
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedDiabetes Mellitus, Type 2Germany
-
Assiut UniversityCompleted
-
Kun HuaRecruitingAtrial Fibrillation | Atrial Fibrillation Recurrence | Cox Maze IV | Patients With or Without Heart Failure and DiabetesChina
-
University of California, San FranciscoNot yet recruitingCystinuriaUnited States
-
Children's Memorial Health Institute, PolandDepartment of Internal Medicine, Hypertension and Vascular Diseases, The...Not yet recruitingGlucose 6 Phosphatase DeficiencyPoland
-
Nanfang Hospital, Southern Medical UniversityCompleted
-
Novo Nordisk A/SWithdrawn
-
Henrik Enghusen PoulsenUniversity of Copenhagen; University Hospital, Gentofte, CopenhagenCompletedDiabetes Mellitus, Type 2Denmark
-
Novartis PharmaceuticalsCompletedRenal ImpairmentUnited States
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Japan
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 1United States, Spain, Taiwan, Belgium, United Kingdom, Germany, Canada, Australia, Finland, Netherlands, Poland, France, Denmark, Norway, Sweden, Austria, Czechia
-
University of MalayaUnknownNAFLD | Type2 DiabetesMalaysia
-
Joslin Diabetes CenterWithdrawnDiabetes, ObesityUnited States
-
Medical University of ViennaUnknownType 2 Diabetes | Metabolically Healthy ControlsAustria
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Japan
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesUnited States, Germany, Poland, Argentina, United Kingdom, Mexico
-
AstraZenecaBristol-Myers SquibbCompletedHypertension | Cardiovascular Disease | Type 2 Diabetes Mellitus | Inadequate Glycaemic ControlUnited States, Vietnam, Germany, Romania, Canada, Argentina, Slovakia, Taiwan, Spain
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Germany
-
Profil Institut für Stoffwechselforschung GmbHCompleted
-
McGill University Health Centre/Research Institute...Diabetes CanadaRecruiting
-
Xinhua Hospital, Shanghai Jiao Tong University...Recruiting
-
University Hospital GoettingenGerman Research FoundationRecruitingChronic Kidney Failure in Children and Young AdultsGermany
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot yet recruiting
-
Assistance Publique - Hôpitaux de ParisRecruitingHeart Failure | Reduced Ejection FractionFrance
-
Wonju Severance Christian HospitalRecruitingType2 Diabetes | Remodeling, VentricularKorea, Republic of
-
Hong Kong Children's HospitalRecruitingGlycogen Storage Disease Type IBHong Kong
-
University of Sao Paulo General HospitalFederal University of São PauloRecruitingDiabetes Mellitus, Type 2 | Diabetes Complications | Kidney TransplantationBrazil
-
The TIMI Study GroupAstraZeneca; Worldwide Clinical TrialsRecruitingHeart Failure | Acute Heart FailureUnited States
-
AstraZenecaFullcro s.r.l.CompletedHeart Failure, Reduced Ejection FractionItaly
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Japan
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2China
-
Boehringer IngelheimEli Lilly and CompanyCompletedMyocardial InfarctionUnited States, Spain, Australia, Denmark, Netherlands, Canada, China, Germany, Korea, Republic of, Israel, Hungary, Japan, Argentina, France, Romania, Russian Federation, Serbia, Ukraine, Poland, India, Brazil, Bulgaria
-
AstraZenecaCompletedHeart Failure | Chronic Kidney DiseaseUnited States, Germany, Italy, Spain, Belgium, Denmark, Thailand, Poland, Canada, Korea, Republic of, Slovakia, Taiwan, Turkey, Ukraine, Japan, Czechia, Hungary, Bulgaria, Russian Federation, Sweden, Lithuania, India
-
Ohio State UniversityDiacompWithdrawn
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Japan
-
Tan Tock Seng HospitalWithdrawnCardiovascular Diseases | End Stage Renal Disease
-
Icahn School of Medicine at Mount SinaiEli Lilly and Company; Boehringer IngelheimCompletedCardiovascular DiseasesUnited States
-
Mariëlle SchefferAstraZenecaUnknownHeart Failure, DiastolicNetherlands
-
Janssen Research & Development, LLCThe George Institute for Global Health, AustraliaCompletedDiabetes Mellitus, Type 2 | Diabetic NephropathyUnited States, Canada, France, Germany, Poland, Ukraine, United Kingdom, China, Taiwan, Spain, Argentina, Colombia, Mexico, Bulgaria, India, Malaysia, Romania, Serbia, South Africa, Japan, Australia, Korea, Republic of, Chile, New Zealand and more